MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced the closing of its public offering of 4,119,300 shares of its common stock at a public offering price of $25.00 per share, including 537,300 shares sold pursuant to the underwriters' option to purchase additional shares. This public offering resulted in total aggregate proceeds of approximately $103.0 mil